The Role of Low-dose of Aspirin in Improving the Subsequent Live-Birth Rate Amongst Women with Unexplained Recurrent Miscarriage

Authors

  • Thawra Naiseh

Abstract

The aim of the study: to assess the value of low-dose aspirin (81mg) daily in Improving the subsequent live-birth rate amongst women with unexplained recurrent miscarriage. In the case of early miscarriage < 13 gestational weeks, there are two groups:

Group I: Took aspirin, The live-birth rate was (46.6%)

Group II: Didn’t take aspirin, the live-birth rate was (43.3%)

There was no significant differences in live-birth rate between those who took aspirin and those who didn’t take it, in women with previous early miscarriage. In contrast, women with previous late miscarriage who took aspirin had a significantly high live birth rate compared with those who didn’t take aspirin.

Downloads

Published

2020-05-29

How to Cite

1.
نعيسه ث. The Role of Low-dose of Aspirin in Improving the Subsequent Live-Birth Rate Amongst Women with Unexplained Recurrent Miscarriage. Tuj-hlth [Internet]. 2020May29 [cited 2024May9];42(2). Available from: https://journal.tishreen.edu.sy/index.php/hlthscnc/article/view/9616

Issue

Vol. 42 No. 2 (2020): Tishreen University Journal -Medical Sciences Series

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

The authors retain the copyright and grant the right to publish in the magazine for the first time with the transfer of the commercial right to Tishreen University Journal for Research and Scientific Studies - Health Sciences Series

 Under a CC BY- NC-SA 04 license that allows others to share the work with of the work's authorship and initial publication in this journal. Authors can use a copy of their articles in their scientific activity, and on their scientific websites, provided that the place of publication is indicted in  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series   .  The Readers have the right to send, print and subscribe to the initial version of the article, and the title of  Tishreen University Journal for Research and Scientific Studies - Health Sciences Series  Publisher

journal uses a CC BY-NC-SA license which mean

You are free to:

  • Adapt — remix, transform, and build upon the material
  •  
  • The licensor cannot revoke these freedoms as long as you follow the license terms.

 

  • Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
  • NonCommercial — You may not use the material for commercial purposes.
  • ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
  • No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.